EC

EcoR1 Capital Portfolio holdings

AUM $1.69B
This Quarter Return
+7.85%
1 Year Return
+7.54%
3 Year Return
+113.08%
5 Year Return
+306.58%
10 Year Return
+4,328.75%
AUM
$2.92B
AUM Growth
+$2.92B
Cap. Flow
-$489M
Cap. Flow %
-16.75%
Top 10 Hldgs %
63.86%
Holding
67
New
12
Increased
7
Reduced
7
Closed
4

Top Buys

1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
$77.2M
2
VRDN icon
Viridian Therapeutics
VRDN
$44.6M
3
MBX
MBX Biosciences, Inc. Common Stock
MBX
$30.5M
4
IONS icon
Ionis Pharmaceuticals
IONS
$20M
5
RLAY icon
Relay Therapeutics
RLAY
$17.7M

Top Sells

1
SRPT icon
Sarepta Therapeutics
SRPT
$222M
2
MORF
Morphic Holding, Inc. Common Stock
MORF
$170M
3
GLPG icon
Galapagos
GLPG
$161M
4
CNTA
Centessa Pharmaceuticals
CNTA
$39.8M
5
ACAD icon
Acadia Pharmaceuticals
ACAD
$21.9M

Sector Composition

1 Healthcare 99.89%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CRGX
26
DELISTED
CARGO Therapeutics
CRGX
$27.1M 0.93%
1,470,000
– –
ADAP
27
Adaptimmune Therapeutics
ADAP
$13.9M
$26M 0.89%
27,404,070
– –
TECX
28
Tectonic Therapeutic, Inc. Common Stock
TECX
$305M
$25.7M 0.88%
849,143
– –
TCRX icon
29
TScan Therapeutics
TCRX
$106M
$24.9M 0.85%
5,000,000
– –
VYGR icon
30
Voyager Therapeutics
VYGR
$204M
$22.9M 0.78%
3,917,546
– –
CLDX icon
31
Celldex Therapeutics
CLDX
$1.57B
$22.1M 0.76%
650,000
– –
BCYC
32
Bicycle Therapeutics
BCYC
$492M
$20.6M 0.7%
910,000
– –
IONS icon
33
Ionis Pharmaceuticals
IONS
$9.64B
$20M 0.69%
+500,000
New +$20M
DYN icon
34
Dyne Therapeutics
DYN
$1.92B
$20M 0.68%
555,644
+128,605
+30% +$4.62M
AVIR icon
35
Atea Pharmaceuticals
AVIR
$275M
$18.2M 0.62%
5,441,896
– –
RLAY icon
36
Relay Therapeutics
RLAY
$709M
$17.7M 0.61%
+2,500,000
New +$17.7M
PHVS icon
37
Pharvaris
PHVS
$1.41B
$16.7M 0.57%
900,000
– –
ITOS
38
DELISTED
iTeos Therapeutics
ITOS
$16.4M 0.56%
1,608,616
-1,641,219
-51% -$16.8M
MDGL icon
39
Madrigal Pharmaceuticals
MDGL
$9.7B
$15.9M 0.54%
75,000
– –
DAWN icon
40
Day One Biopharmaceuticals
DAWN
$766M
$12M 0.41%
+862,068
New +$12M
KROS icon
41
Keros Therapeutics
KROS
$640M
$10.9M 0.37%
187,500
– –
REPL icon
42
Replimune Group
REPL
$460M
$9.32M 0.32%
850,341
– –
KLRS
43
Kalaris Therapeutics, Inc. Common Stock
KLRS
$85.5M
$9.13M 0.31%
11,294,585
– –
LENZ
44
LENZ Therapeutics
LENZ
$1.12B
$8.23M 0.28%
346,772
-873,002
-72% -$20.7M
VERV
45
DELISTED
Verve Therapeutics
VERV
$6.05M 0.21%
1,250,000
– –
GBIO icon
46
Generation Bio
GBIO
$40.3M
$5.06M 0.17%
2,046,867
– –
GLPG icon
47
Galapagos
GLPG
$2.06B
$4.46M 0.15%
155,006
-5,601,262
-97% -$161M
BBIO icon
48
BridgeBio Pharma
BBIO
$9.91B
$4.33M 0.15%
+170,172
New +$4.33M
ATRA icon
49
Atara Biotherapeutics
ATRA
$88.7M
$3.81M 0.13%
468,938
+62,259
+15% +$506K
WHWK
50
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.3M
$3.8M 0.13%
+1,845,253
New +$3.8M
1
2
3